Table 3.
Standardized mortality ratios overall and by duration of employment, NIOSH Capacitor Cohort, 1960–2008.a
| Underlying cause of deathb | Entire cohort (n = 24,865) |
Short-term workersc (n = 7647) |
Long-term workersc (n = 17,218) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| OBS | SMRd | 95% CI | OBS | SMR | 95% CI | OBS | SMR | 95% CI | |
| All causes | 8688 | 0.99 | 0.97–1.01 | 2255 | 1.17 | 1.12–1.22 | 6433 | 0.94 | 0.91–0.96 |
| All cancers | 2593 | 1.06 | 1.02–1.10 | 686 | 1.20 | 1.11–1.30 | 1907 | 1.01 | 0.97–1.06 |
| MN of buccal cavity and pharynx | 45 | 1.12 | 0.82–1.50 | 17 | 1.89 | 1.10–3.03 | 28 | 0.90 | 0.60–1.29 |
| MN of tongue | 12 | 1.25 | 0.65–2.18 | 3 | 1.38 | 0.28–4.02 | 9 | 1.21 | 0.55–2.30 |
| MN of other parts of buccal cavity | 15 | 1.36 | 0.76–2.24 | 4 | 1.67 | 0.46–4.28 | 11 | 1.27 | 0.64–2.28 |
| MN of pharynx | 18 | 0.94 | 0.56–1.48 | 10 | 2.31 | 1.11–4.25 | 8 | 0.54 | 0.23–1.06 |
| MN of digestive organs and peritoneum | 603 | 1.09 | 1.00–1.18 | 151 | 1.23 | 1.04–1.44 | 452 | 1.05 | 0.95–1.15 |
| MN of esophagus | 60 | 1.21 | 0.92–1.55 | 10 | 0.90 | 0.43–1.66 | 50 | 1.29 | 0.96–1.71 |
| MN of stomach | 58 | 1.04 | 0.79–1.35 | 12 | 1.01 | 0.52–1.77 | 46 | 1.05 | 0.77–1.40 |
| MN of intestine except rectum | 231 | 1.11 | 0.97–1.27 | 56 | 1.23 | 0.93–1.60 | 175 | 1.08 | 0.92–1.25 |
| MN of rectum | 50 | 1.21 | 0.90–1.59 | 9 | 0.98 | 0.45–1.85 | 41 | 1.27 | 0.91–1.73 |
| MN of biliary passages, liver and gall bladder | 63 | 0.98 | 0.76–1.26 | 19 | 1.29 | 0.78–2.01 | 44 | 0.89 | 0.65–1.20 |
| MN of pancreas | 136 | 1.08 | 0.90–1.28 | 42 | 1.47 | 1.06–1.98 | 94 | 0.96 | 0.78–1.18 |
| MN of peritoneum and other and unspecified of digestive organs | 5 | 0.53 | 0.17–1.24 | 3 | 1.40 | 0.29–4.10 | 2 | 0.27 | 0.03–0.99 |
| MN of respiratory system | 797 | 1.08 | 1.00–1.15 | 230 | 1.35 | 1.19–1.54 | 567 | 0.99 | 0.91–1.08 |
| MN of larynx | 24 | 1.32 | 0.85–1.97 | 8 | 2.04 | 0.88–4.02 | 16 | 1.13 | 0.64–1.83 |
| MN of trachea, bronchus, and lung | 766 | 1.07 | 0.99–1.15 | 221 | 1.34 | 1.17–1.53 | 545 | 0.99 | 0.91–1.07 |
| MN other parts of respiratory system | 7 | 1.52 | 0.61–3.14 | 1 | 0.91 | 0.02–5.09 | 6 | 1.71 | 0.63–3.72 |
| MN of breast | 239 | 1.01 | 0.89–1.15 | 74 | 1.15 | 0.90–1.44 | 165 | 0.96 | 0.82–1.12 |
| MN of female genital organs | 143 | 1.00 | 0.84–1.18 | 39 | 1.03 | 0.73–1.41 | 104 | 0.99 | 0.81–1.20 |
| MN of cervix uteri | 31 | 1.12 | 0.76–1.60 | 10 | 1.29 | 0.62–2.37 | 21 | 1.06 | 0.66–1.62 |
| MN of other and unspecified parts of uterus | 34 | 1.07 | 0.74–1.50 | 6 | 0.75 | 0.28–1.63 | 28 | 1.18 | 0.78–1.70 |
| MN of ovary, fallopian tube, and broad ligament | 69 | 0.88 | 0.68–1.11 | 20 | 0.96 | 0.59–1.48 | 49 | 0.85 | 0.63–1.13 |
| MN of other female genital organs | 9 | 1.75 | 0.80–3.32 | 3 | 2.38 | 0.49–6.95 | 6 | 1.54 | 0.57–3.36 |
| MN of male genital organs | 87 | 0.96 | 0.77–1.18 | 9 | 0.57 | 0.26–1.09 | 78 | 1.04 | 0.82–1.30 |
| MN of prostate | 87 | 0.99 | 0.80–1.23 | 9 | 0.61 | 0.28–1.16 | 78 | 1.07 | 0.85–1.34 |
| MN of urinary organs | 109 | 1.08 | 0.89–1.31 | 31 | 1.43 | 0.97–2.02 | 78 | 0.99 | 0.78–1.24 |
| MN of kidney | 56 | 1.03 | 0.78–1.34 | 14 | 1.12 | 0.61–1.88 | 42 | 1.01 | 0.73–1.36 |
| MN of bladder and other urinary organs | 53 | 1.15 | 0.86–1.50 | 17 | 1.84 | 1.07–2.95 | 36 | 0.97 | 0.68–1.35 |
| MN of other and unspecified sites | 335 | 1.06 | 0.95–1.18 | 80 | 1.06 | 0.84–1.32 | 255 | 1.06 | 0.94–1.20 |
| MN of bone | 6 | 1.12 | 0.41–2.44 | 3 | 2.25 | 0.46–6.59 | 3 | 0.75 | 0.15–2.18 |
| Melanoma | 47 | 1.20 | 0.88–1.60 | 6 | 0.60 | 0.22–1.30 | 41 | 1.41 | 1.01–1.91 |
| Other MN of skin | 9 | 0.93 | 0.42–1.76 | 4 | 1.87 | 0.51–4.78 | 5 | 0.66 | 0.21–1.54 |
| Mesothelioma | 7 | 1.53 | 0.61–3.15 | 1 | 0.94 | 0.02–5.26 | 6 | 1.70 | 0.62–3.71 |
| MN of connective tissue | 14 | 0.94 | 0.51–1.57 | 3 | 0.78 | 0.16–2.27 | 11 | 0.99 | 0.50–1.77 |
| MN of brain and other parts of nervous system | 67 | 1.01 | 0.78–1.28 | 14 | 0.83 | 0.45–1.39 | 53 | 1.07 | 0.80–1.40 |
| MN of thyroid gland | 3 | 0.52 | 0.11–1.53 | 0 | 0.00 | 0.00–2.76 | 3 | 0.68 | 0.14–2.00 |
| MN of other and unspecified sites | 181 | 1.07 | 0.92–1.24 | 49 | 1.27 | 0.94–1.68 | 132 | 1.02 | 0.85–1.21 |
| Neoplasms of lymphatic and hematopoietic tissue | 235 | 1.01 | 0.88–1.15 | 55 | 1.02 | 0.77–1.33 | 180 | 1.01 | 0.86–1.16 |
| Hodgkin disease | 9 | 0.76 | 0.35–1.45 | 4 | 1.28 | 0.35–3.27 | 5 | 0.58 | 0.19–1.35 |
| Non-Hodgkin lymphoma | 93 | 0.99 | 0.80–1.21 | 24 | 1.11 | 0.71–1.65 | 69 | 0.95 | 0.74–1.20 |
| Multiple myeloma | 45 | 1.12 | 0.82–1.50 | 4 | 0.45 | 0.12–1.14 | 41 | 1.31 | 0.94–1.78 |
| Leukemia and aleukemia | 88 | 1.02 | 0.82–1.25 | 23 | 1.15 | 0.73–1.73 | 65 | 0.98 | 0.75–1.24 |
| Benign and unspecified neoplasms | 30 | 0.90 | 0.61–1.29 | 9 | 1.19 | 0.54–2.25 | 21 | 0.82 | 0.51–1.26 |
| Tuberculosis and HIV-related disease | 47 | 1.23 | 0.91–1.64 | 32 | 2.80 | 1.91–3.95 | 15 | 0.56 | 0.32–0.93 |
| Respiratory tuberculosis | 3 | 0.47 | 0.10–1.36 | 1 | 0.81 | 0.02–4.50 | 2 | 0.38 | 0.05–1.39 |
| HIV-related | 44 | 1.45 | 1.06–1.95 | 31 | 3.13 | 2.13–4.44 | 13 | 0.64 | 0.34–1.09 |
| Diseases of the blood and blood forming organs | 32 | 0.89 | 0.61–1.25 | 3 | 0.38 | 0.08–1.12 | 29 | 1.02 | 0.69–1.47 |
| Diabetes mellitus | 206 | 0.91 | 0.79–1.04 | 54 | 1.05 | 0.79–1.36 | 152 | 0.87 | 0.74–1.02 |
| Mental, psychoneurotic, and personality disorders | 113 | 0.84 | 0.69–1.01 | 39 | 1.40 | 0.99–1.91 | 74 | 0.69 | 0.54–0.87 |
| Alcoholism | 19 | 0.60 | 0.36–0.94 | 10 | 1.20 | 0.58–2.21 | 9 | 0.39 | 0.18–0.74 |
| Other mental disorders | 94 | 0.91 | 0.74–1.12 | 29 | 1.48 | 0.99–2.12 | 65 | 0.78 | 0.60–0.99 |
| Dementia and Alzheimer diseasee | 116 | 1.04 | 0.86–1.24 | 32 | 1.57 | 1.08–2.22 | 84 | 0.92 | 0.73–1.14 |
| Disorders of the nervous system and sense organs | 254 | 1.09 | 0.96–1.24 | 60 | 1.22 | 0.93–1.57 | 194 | 1.06 | 0.92–1.22 |
| Multiple sclerosis | 14 | 0.91 | 0.50–1.53 | 3 | 0.68 | 0.14–1.98 | 11 | 1.01 | 0.50–1.81 |
| Other diseases of the nervous system and sense organs | 240 | 1.11 | 0.97–1.26 | 57 | 1.27 | 0.96–1.65 | 183 | 1.07 | 0.92–1.23 |
| Amyotrophic lateral sclerosise | 31 | 1.34 | 0.91–1.90 | 11 | 1.95 | 0.97–3.50 | 20 | 1.14 | 0.70–1.76 |
| Parkinson diseasee | 45 | 1.14 | 0.83–1.52 | 3 | 0.42 | 0.09–1.22 | 42 | 1.30 | 0.94–1.76 |
| Diseases of the heart | 2520 | 0.96 | 0.92–1.00 | 593 | 1.14 | 1.05–1.23 | 1927 | 0.92 | 0.87–0.96 |
| Rheumatic heart disease, including fever | 28 | 0.71 | 0.47–1.03 | 6 | 0.71 | 0.26–1.55 | 22 | 0.71 | 0.45–1.08 |
| Hypertension with heart disease | 60 | 0.71 | 0.54–0.92 | 19 | 1.07 | 0.65–1.68 | 41 | 0.62 | 0.44–0.84 |
| Ischemic heart disease | 1984 | 0.96 | 0.92–1.01 | 454 | 1.12 | 1.02–1.23 | 1530 | 0.92 | 0.88–0.97 |
| Chronic disease of endocardium | 44 | 0.87 | 0.63–1.17 | 7 | 0.69 | 0.28–1.42 | 37 | 0.91 | 0.64–1.26 |
| Cardiomyopathy | 86 | 1.08 | 0.86–1.33 | 27 | 1.50 | 0.99–2.18 | 59 | 0.96 | 0.73–1.23 |
| Conduction disorder | 148 | 1.08 | 0.91–1.27 | 42 | 1.46 | 1.05–1.98 | 106 | 0.98 | 0.80–1.19 |
| Other diseases of the heart | 170 | 0.98 | 0.84–1.14 | 38 | 1.12 | 0.79–1.54 | 132 | 0.95 | 0.79–1.12 |
| Other diseases of the circulatory system | 734 | 0.96 | 0.89–1.03 | 136 | 0.89 | 0.74–1.05 | 598 | 0.98 | 0.90–1.06 |
| Cerebrovascular disease | 478 | 0.94 | 0.85–1.02 | 89 | 0.88 | 0.71–1.09 | 389 | 0.95 | 0.86–1.05 |
| Hypertension without heart disease | 43 | 0.96 | 0.69–1.29 | 3 | 0.32 | 0.07–0.95 | 40 | 1.12 | 0.80–1.53 |
| Diseases of the arteries, veins and lymphatic vessel | 213 | 1.02 | 0.88–1.16 | 44 | 1.02 | 0.74–1.37 | 169 | 1.02 | 0.87–1.18 |
| Diseases of the respiratory system | 725 | 0.98 | 0.91–1.06 | 196 | 1.29 | 1.11–1.48 | 529 | 0.91 | 0.83–0.99 |
| Influenza | 3 | 0.59 | 0.12–1.73 | 0 | 0.00 | 0.00–3.67 | 3 | 0.74 | 0.15–2.15 |
| Pneumonia (except newborn) | 213 | 1.07 | 0.93–1.23 | 51 | 1.32 | 0.98–1.74 | 162 | 1.01 | 0.86–1.18 |
| Chronic obstructive pulmonary disease | 400 | 1.00 | 0.91–1.10 | 118 | 1.40 | 1.16–1.68 | 282 | 0.90 | 0.79–1.01 |
| Asthma | 16 | 0.97 | 0.55–1.57 | 6 | 1.47 | 0.54–3.21 | 10 | 0.80 | 0.38–1.47 |
| Other respiratory diseases | 89 | 0.81 | 0.65–1.00 | 21 | 0.90 | 0.56–1.38 | 68 | 0.78 | 0.61–0.99 |
| Diseases of the digestive system | 320 | 0.85 | 0.76–0.95 | 96 | 1.11 | 0.90–1.36 | 224 | 0.78 | 0.68–0.89 |
| Diseases of the skin and subcutaneous tissue | 8 | 0.75 | 0.32–1.48 | 0 | 0.00 | 0.00–1.58 | 8 | 0.96 | 0.41–1.89 |
| Diseases of the musculoskeletal system and connective system | 33 | 0.85 | 0.58–1.19 | 10 | 1.09 | 0.52–2.00 | 23 | 0.78 | 0.49–1.16 |
| Diseases of the genito-urinary system | 136 | 0.89 | 0.75–1.05 | 34 | 1.08 | 0.74–1.50 | 102 | 0.84 | 0.69–1.02 |
| Chronic and unspecified nephritis and renal failure and other renal sclerosis | 90 | 1.12 | 0.90–1.38 | 25 | 1.46 | 0.95–2.16 | 65 | 1.03 | 0.80–1.32 |
| Symptoms and ill-defined conditions | 45 | 0.52 | 0.38–0.70 | 16 | 0.79 | 0.45–1.29 | 29 | 0.44 | 0.29–0.63 |
| Transportation injuries | 167 | 0.78 | 0.66–0.91 | 60 | 0.94 | 0.72–1.21 | 107 | 0.71 | 0.58–0.86 |
| Falls | 39 | 0.70 | 0.50–0.96 | 2 | 0.17 | 0.02–0.61 | 37 | 0.85 | 0.60–1.17 |
| Other injury | 120 | 0.79 | 0.66–0.95 | 49 | 1.19 | 0.88–1.57 | 71 | 0.65 | 0.50–0.81 |
| Intentional self-harm | 110 | 0.73 | 0.60–0.88 | 39 | 0.92 | 0.66–1.26 | 71 | 0.66 | 0.51–0.83 |
| Assault and homicide | 23 | 0.44 | 0.28–0.67 | 13 | 0.82 | 0.44–1.40 | 10 | 0.28 | 0.13–0.51 |
| Other causes | 207 | 0.91 | 0.79–1.04 | 64 | 1.17 | 0.90–1.49 | 143 | 0.82 | 0.69–0.97 |
| Unknown cause | 226 | 64 | 162 | ||||||
Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus; OBS, observed deaths; MN, malignant neoplasm; SMR, standardized mortality ratio.
All results exclude workers who died (n = 61) or were lost to follow-up (n = 324) prior to the rate file begin date (1 January 1960).
International Classification of Disease (ICD) codes were mapped to underlying cause of death categories as described by Robinson et al. (2006) and tabulated on the NIOSH website (http://www.cdc.gov/niosh/ltas/rates.html). All major categories of causes of death are presented. Some minor categories of causes of death are not presented because there were two or fewer deaths in the category or the category was not of a priori interest and the SMR was not in statistically significant excess.
Short-term workers worked less than 3 months; long-term workers worked 3 months or longer.
The SMR is the ratio of observed to expected (based on US underlying cause of death rates, 1960–2007) deaths; 95% CI was estimated based on the Poisson distribution.
Neurodegenerative outcomes based on US underlying cause of death rates, 1960–2007. Dementia and Alzheimer disease (excluding arteriosclerotic dementia) includes ICD codes 304–305 (revision 7), 290.0–290.1 (revision 8), 290.0–290.3 and 331.0 (revision 9), and G30 (revision 10); amyotrophic lateral sclerosis includes ICD codes 306 (revision 7), 348.0 (revision 8), 335.2 (revision 9), and F01 (revision 10); and Parkinson disease includes ICD codes 350 (revision 7), 342 (revision 8), 332 (revision 9), and G20–G21 (revision 10).